Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.
about
Redox mechanisms in hepatic chronic wound healing and fibrogenesisCARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cellsLiver fibrosisHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverSinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD.Treatment of non-alcoholic fatty liver disease.Animal models for the study of liver fibrosis: new insights from knockout mouse models.Plasminogen activator inhibitor-1 deficient mice are protected from angiotensin II-induced fibrosisAliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet.The immune system and hypertension.The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort.Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cellsSalvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II SignalingNADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.Therapeutic potential of targeting the renin angiotensin system in portal hypertension.Angiotensin converting enzyme 2 (ACE2) activity in fetal calf serum: implications for cell culture research.Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitisOxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 ratsPortal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.Alcoholic liver disease and the potential role of plasminogen activator inhibitor-1 and fibrin metabolism.Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis CThe role of the renin-angiotensin system in liver fibrosis.Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes.Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.Angiotensin II participates in hepatic inflammation and fibrosis through MCP-1 expression.Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease.Involvement of the HIF-1α and Wnt/β-catenin pathways in the protective effects of losartan on fatty liver graft with ischaemia/reperfusion injury.Angiotensin II increases mRNA levels of all TGF-beta isoforms in quiescent and activated rat hepatic stellate cells.Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats.Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver.Angiotensin-(1-7), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat.Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice.Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue.
P2860
Q24656684-26DE544F-AC69-411E-9A3E-08A61401C91DQ24675332-C4635DCD-983C-47A7-836D-3EB0AF80A2D9Q29547449-FE475319-1398-413A-AEBF-284ADDB2F800Q29616840-87CAC33A-98F3-445F-8FFA-94B69B174B59Q34234946-755B5943-A631-4F09-82B7-CA9DF2FE6E2CQ34592654-E8EFCB3C-EA39-48EC-8B95-13220BE68EF3Q34979933-AB3BDB3B-6C0C-4D9B-AD10-4C5867A2C76AQ34984527-DC5AA37B-F82F-416F-B8E8-37027D17BCBBQ35035662-6582FC74-D437-4D43-AE16-3F3CDF84AED2Q35038155-F74BEEE0-F425-4415-A8D4-0A0236B88A6CQ35124395-8FCD7E01-4B82-41AD-80B9-A199EC1E750DQ35569812-A9D78537-352C-446F-A8A7-2831B8C6F8C8Q36456025-897854DE-41BE-4294-8DDB-811A54D6A6B6Q36524368-2ADFC1F2-C07D-4A0E-ACBB-94C0F2BD8CFAQ36526062-E29910DF-5EFF-4DFA-BE10-AA89ED2AFEAFQ36769062-76F0ADF0-5135-417E-BCF1-9BB7B37F3C4FQ37120331-5F85FBCF-E9F7-40CD-938D-244A030935E0Q37122480-2FB20D23-EDFF-42FE-8039-22C79301D5F7Q37164536-2324E017-C99F-4D8E-84E6-0A43353CF853Q37264506-AD017373-A70B-4FED-A075-8A08647BF8E7Q37305691-02F21F53-4706-4C03-A9A4-933E4EA0AD36Q37313049-86AF7E28-C533-42CF-B66F-121168EC4FECQ37391823-3594CFA8-ED80-451B-8BAF-319BBB9B1DD3Q37867350-D1ED2C42-D2A2-4C15-BDFD-CCD91972DC28Q38006726-EF476820-5C90-4B8C-BD75-01630C3D16E6Q38560320-218654CD-A0EA-4512-BEA4-19A10567D9ADQ38753755-0A5134C3-BDDD-4F32-9B40-BF9580723972Q38879747-0DE5E13F-71D4-419A-8963-E1A1E673CB44Q40419536-B521120F-9E5D-4028-A978-789F53D5BDBBQ41825863-F045987E-D20F-4111-B909-D22AA34599BDQ42213010-22B79802-BC95-4B1A-B3D9-56BBDE59AED7Q42710189-67FD177B-DC4A-445E-833B-710924F5FAF8Q43015011-E7C62387-35D2-48B6-9834-792C622EEBBEQ43078753-6CE096FA-B503-4448-A12D-FEB292A792FFQ45190324-F6F7D9A7-5F87-459A-8C48-2BEA4D6AAF49Q45255856-41F0A48C-3270-4600-9634-FBFE6534FFCEQ46213897-F0307683-4715-48B4-B10E-FBA4C6CE83B4Q46967668-AB264293-C0C7-450C-A559-23A7349D6FEBQ48607830-ADE2067A-2170-4A05-ACBA-C51300371E49Q49345079-25B9FD03-7274-4536-8630-850ED3F38610
P2860
Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Prolonged infusion of angioten ...... oinflammatory events in liver.
@en
Prolonged infusion of angioten ...... oinflammatory events in liver.
@nl
type
label
Prolonged infusion of angioten ...... oinflammatory events in liver.
@en
Prolonged infusion of angioten ...... oinflammatory events in liver.
@nl
prefLabel
Prolonged infusion of angioten ...... oinflammatory events in liver.
@en
Prolonged infusion of angioten ...... oinflammatory events in liver.
@nl
P2093
P2860
P356
P1476
Prolonged infusion of angioten ...... oinflammatory events in liver.
@en
P2093
Erwin Gäbele
Mark Lehnert
Ramón Bataller
Richard A Rippe
Robert Schoonhoven
Terry Morris
P2860
P304
P356
10.1152/AJPGI.00037.2003
P577
2003-05-28T00:00:00Z